Microparticles in Pediatric Inflammatory Disease
|Study Design:||Observational Model: Case Control
Time Perspective: Cross-Sectional
|Official Title:||Microparticles in Pediatric Inflammatory Bowel Disease|
|Study Start Date:||August 2009|
|Study Completion Date:||May 2011|
|Primary Completion Date:||May 2011 (Final data collection date for primary outcome measure)|
Once the response of microparticles to inflammation is defined in this patient population, the microparticles can be used as biomarkers of disease activity and could potentially use microparticles as targets of therapeutic agents.
This cross sectional study will enroll 15 Crohn's patients (5 inactive, 5 mild, 5 moderate-severe disease based on the pediatric Crohn's disease activity index), 15 Ulcerative Colitis patients (5 inactive, 5 mild, 5 moderate-severe disease based on the pediatric ulcerative colitis activity index), and 10 healthy controls.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00979485
|United States, Indiana|
|Indiana Unversity, Riley Hospital for Children|
|Indianapolis, Indiana, United States, 46202|
|Principal Investigator:||Steven ` Steiner, MD||Indiana University|